Efficacy and Safety of Levalbuterol in Chronic Obstructive Pulmonary Disease (COPD)
Public ClinicalTrials.gov record NCT00665600. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Randomized, Multicenter, Parallel-Group Study of Levalbuterol in the Treatment of Subjects With Chronic Obstructive Pulmonary Disease
Study identification
- NCT ID
- NCT00665600
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Sumitomo Pharma America, Inc.
- Industry
- Enrollment
- 257 participants
Conditions and interventions
Conditions
Interventions
- Levalbuterol HCl Drug
- Albuterol Sulfate Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 35 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2002
- Primary completion
- Feb 28, 2003
- Completion
- Feb 28, 2003
- Last update posted
- Jun 26, 2023
2002 – 2003
United States locations
- U.S. sites
- 20
- U.S. states
- 15
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Carmichael | California | — | — |
| Not listed | Spring Valley | California | — | — |
| Not listed | Wheat Ridge | Colorado | — | — |
| Not listed | Largo | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | Panama City | Florida | — | — |
| Not listed | Atlanta | Georgia | — | — |
| Not listed | Elk Grove Village | Illinois | — | — |
| Not listed | Hines | Illinois | — | — |
| Not listed | Wheaton | Maryland | — | — |
| Not listed | Springfield | Massachusetts | — | — |
| Not listed | Cadillac | Michigan | — | — |
| Not listed | Columbia | Missouri | — | — |
| Not listed | Missoula | Montana | — | — |
| Not listed | Springfield | New Jersey | — | — |
| Not listed | Chapel Hill | North Carolina | — | — |
| Not listed | Mogadore | Ohio | — | — |
| Not listed | Providence | Rhode Island | — | — |
| Not listed | Austin | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00665600, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 26, 2023 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00665600 live on ClinicalTrials.gov.